TGen Awarded $1.99 Million Grant to Advance Highly Parallel Supercomputing 

TGen  and ASU scientists are collaborating on a variety of research projects that develop and examine molecular profiles of human diseases and fundamental pathways involved in disease states. The focus is to discern complex or simple sets of biomarkers useful for disease diagnosis and prognosis, as well as to develop molecular classification for directing optimal therapeutic choice and identifying new targets. The molecular profile datasets being analyzed cover diseases including: Alzheimer's, autism, diabetes, coronary heart disease, malignant gliomas, melanoma, pancreatic cancer, prostate cancer, colon cancer, multiple myeloma, and breast cancer.

Arizona Biotech - Biotech News